INTRODUCTION {#rjw235s1}
============

Prosthetic joint infection (PJI) following total hip replacement (THR) occurs in 1--2% of procedures but is one of the primary reasons for prosthesis revision (1). We report the only case of *Streptococcus gordonii*, a member of the viridans group streptococci (VGS), causing PJI in the setting of THR.

CASE REPORT {#rjw235s2}
===========

A 69-year-old female, with a number of comorbidities, presented with an 1-day history of rigors, fever (39°C) and severe left groin pain on a background of previous bilateral cementless THRs, left THR 4 years previously and right THR 2 years previously. Her radiographs demonstrated a well-fixed implant and no periprosthetic fracture (Fig. [1](#rjw235F1){ref-type="fig"}). Blood results showed a leucocytosis (white cell count (WCC) 22.3 × 10^9^ l^--1^) and elevated C-reactive protein (CRP, 211 mg/l). Blood cultures were negative. Examination on this admission revealed a chronic sinus infection in a left upper incisor not noted on her last dental review 10 months previously. The patient described no history of gum or tooth sensitivity and pain. An orthopantomogram was done which showed multiple dental fillings but no sign of dental abscess (Fig. [2](#rjw235F2){ref-type="fig"}). An echocardiogram done to out rule endocarditis was normal. A computed tomography scan revealed extensive soft tissue swelling over the left hip involving the psoas muscle (Fig. [3](#rjw235F3){ref-type="fig"}). Ultrasound-guided aspiration was performed and 30 ml of purulent fluid was aspirated. Following this empiric antibiotics (vancomycin and gentamicin) were started. The hip aspirate grew *S. gordonii* (MALDI-TOF, Bruker) that was pansensitive. Antibiotics were rationalized following consultation with the Microbiology Department. Despite a discussion in which the need for replacement of the prosthesis was had, the patient choose to initially trial conservative management with intravenous antibiotics due to her pre-existing comorbidities and wish to avoid further surgery. The risks of this course of management were explained including the ultimate need for prosthesis replacement. A 6-week course of intravenous ceftriaxone was started and was successful in normalizing her inflammatory markers (WCC 7 × 10^9^ l^--1^, CRP \< 5 mg/l). She was placed on long-term suppressive amoxicillin following this and underwent extraction of her left upper incisor 2 weeks after the completion of her intravenous antibiotics. Unfortunately, 6 months into her treatment she developed fever, nausea and diarrhoea, and a stool sample was positive for clostridium difficile. Her antibiotics were rationalized to Doxycycline. Since then serial monthly blood tests have remained normal. At 1-year follow-up, she was asymptomatic. She had experienced no further episodes of groin pain or fever and had returned to her baseline level of mobility. Her Oxford hip score was 43 out of 48. Blood results showed a WCC of 6.7 × 10^9^ l^--1^ and a CRP of 11 mg/l. Figure 1:X-ray pelvis---showing bilateral well-fixed THRs.Figure 2:Orthopantomogram---showing dental implants and fillings.Figure 3:Computed tomography scan showing left iliopsoas involvement and heterogeneity, with a well-defined intramuscular hypoattenuation typical for abscess formation.

DISCUSSION {#rjw235s3}
==========

PJI occurs via direct inoculation, contiguous or haematogenous spread. Late onset infections (\>12 months after surgery) are predominantly due to haematogenous seeding of virulent pathogens at another site (urinary tract, soft tissue infection). PJI is primarily caused by staphylococci with only a small percentage caused by streptococci, \<10% \[[@rjw235C1], [@rjw235C2]\]. *Streptococcus gordonii*, a member of the Streptococcus Sanguinis group, a subdivision of VGS, is one of the microbiota of the oral cavity that contributes to plaque formation. It is recognized in the setting of bacterial endocarditis \[[@rjw235C3]\], but has only recently been described in the literature as causing PJI, in the setting of total knee replacement reported in 2015 \[[@rjw235C4]\].

The reasons for the emergence of *S. gordonii* in PJI are not certain. One reason may be due to improved diagnostic technologies. Historically, the automated identification systems for VGS have been problematic due to changing taxonomy and addition of new species. Another reason for this is that all species are not represented in identification databases \[[@rjw235C5], [@rjw235C6]\]. In our institution, we have moved from API Strep (Biomérieux) identification system to MALDI-TOF (Bruker) identification allowing us now to accurately identify members of the streptococcus genus. Exact identification of the streptococcal organism is important, if further aspirations are required in order to reduce confusion that may result if different organisms are detected.

Treatment of PJI is a complex and challenging practice. Guidelines advise debridement, antibiotics and implant retention for patients who present with a well-fixed implant and no sinus tract within 30 days of implantation \[[@rjw235C7], [@rjw235C8]\]. For other patient\'s, replacement of the prosthesis or resection arthroplasty should be performed \[[@rjw235C9]\]. Rarely, medical therapy alone may be considered where medical comorbidities preclude against the above or where patient\'s autonomy must be respected. In our case, the patient was reluctant to undergo any further surgery. Little research exists regarding the treatment of PJI with antibiotics alone and the role of suppressive long-term antibiotics. Treatment failure with suppressive antibiotics is most commonly seen with staphylococci bacteria \[[@rjw235C10]\]. Chronic suppressive antibiotics are not without their risks, as seen in our case. It is important that fully informed consent is achieved prior to beginning the above treatment.

While the rate of PJI is low, the increasing demand for joint replacement will cause a considerable burden of infection in the future. Recognizing and managing PJI promptly is vital in reducing patient morbidity and mortality as well as costs \[[@rjw235C11], [@rjw235C12]\]. PJI will impose increasing challenges due to an ageing population, comorbidities and the emergence of increased antimicrobial resistance. Our case highlights a previously undescribed pathogen in late PJI post-THR.
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